Evolutionary Dynamics and Intermittent Therapy for Metastatic Cancers

J Clin Oncol. 2023 Oct 1;41(28):4469-4471. doi: 10.1200/JCO.23.00647. Epub 2023 Jul 7.

Abstract

Mathematical models show that the induction period of intermittent cancer therapy drives cancer toward resistance

MeSH terms

  • Antineoplastic Agents, Hormonal
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms, Second Primary*

Substances

  • Antineoplastic Agents, Hormonal